Your browser doesn't support javascript.
loading
Natalizumab treatment reduces endothelial activity in MS patients.
Millonig, Alban; Hegen, Harald; Di Pauli, Franziska; Ehling, Rainer; Gneiss, Claudia; Hoelzl, Martina; Künz, Bettina; Lutterotti, Andreas; Rudzki, Dagmar; Berger, Thomas; Reindl, Markus; Deisenhammer, Florian.
Affiliation
  • Millonig A; Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.
J Neuroimmunol ; 227(1-2): 190-4, 2010 Oct 08.
Article in En | MEDLINE | ID: mdl-20739072
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Migration Inhibition / Endothelium, Vascular / Antibodies, Monoclonal / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Neuroimmunol Year: 2010 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Migration Inhibition / Endothelium, Vascular / Antibodies, Monoclonal / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Neuroimmunol Year: 2010 Document type: Article Affiliation country: Country of publication: